Q & A

Read the latest PLC CEO interviews. CEO’s from UK listed PLC’s, Analysts and Fund Managers answering questions about their business.

DWF Group Analyst Q&A with Zeus Capital (LON:DWF)

DWF Group (LON:DWF) is the topic of conversation when Zeus Capital’s Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview. Q1: DWF Group recently completed their..

Analyst Q&A with Hardman & Co CEO Keith Hiscock

Hardman and Co’s CEO Keith Hiscock caught up with DirectorsTalk for an exclusive interview to talk through his latest report ‘Share ownership: for the many, not the few’. Q1: You..

Touchstone Exploration Q&A: Cascadura well is a real gamechanger (LON:TXP)

Touchstone Exploration (LON:TXP) Chief Executive Officer Paul Baay caught up with DirectorsTalk for an exclusive interview to discuss their latest Cascadura update, potential production & growth, drilling of other wells..

RM Secured Direct Lending Analyst Q&A with Hardman & Co (LON:RMDL)

RM Secured Direct Lending (LON:RMDL) is the topic of conversation when Hardman and Co’s Financial Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: You called your..

Real Estate Credit Investments Analyst Q&A (LON:RECI)

Real Estate Credit Investments (LON:RECI) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: You called your recent..

B-North Q&A with Hardman & Co Analyst Mark Thomas

B-North is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: You called your recent piece “B-North – Unquoted..

Norman Broadbent Q&A: Partnership with UN Women UK (LON:NBB)

Norman Broadbent (LON:NBB) Chief Executive Officer Mike Brennan caught up with DirectorsTalk for an exclusive interview to discuss their partnership with UN Women UK, what this means for the company..

Touchstone Exploration Q&A: Transformational oil discovery at Cascadura (LON:TXP)

Touchstone Exploration (LON:TXP) Chief Executive Officer Paul Baay caught up with DirectorsTalk for an exclusive interview to discuss the significant oil discovery at Cascadura, confidence in the remaining two wells..

Kromek Group Q&A: More growth to come in the second half (LON:KMK)

Kromek Group (LON:KMK) Chief Executive Officer Arnab Basu caught up with DirectorsTalk for an exclusive interview to discuss their record first-half revenue, highlights from their interim results and what we..

Versarien Q&A: Significant progress with graphene commercialisation strategy (LON:VRS)

Versarien (LON:VRS) Chief Executive Officer Neill Ricketts caught up with DirectorsTalk for an exclusive interview to discuss the interim results, their graphene commercialisation strategy, mainstream projects and how 2020 is..

ImmuPharma Q&A with The Life Sciences Division (LON:IMM)

ImmuPharma (LON:IMM) is the topic of conversation when The Life Sciences Division’s Executive Director and Head of Research Navid Malik caught up with DirectorsTalk for an exclusive interview. Q1: Firstly,..

Pantheon International Analyst Q&A: Significant long-term out-performance (LON:PIN)

Pantheon International (LON:PIN) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: You titled your piece “History of..

Hardide Q&A Record revenue & a strong start to new financial year (LON:HDD)

Hardide (LON:HDD) Chief Executive Officer Philip Kirkham caught up with DirectorsTalk for an exclusive interview to discuss record revenues, the broadening of customer & sector base, new bigger premises and..

Palace Capital Analyst Q&A with Hardman & Co (LON:PCA)

Palace Capital (LON:PCA) is the topic of conversation when Hardman and Co’s Analyst Mike Foster caught up with DirectorsTalk for an exclusive interview. Q1: PCA has reported results, what is..

Non-Standard Finance Analyst Q&A (LON:NSF)

Non-Standard Finance (LON:NSF) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: Non-Standard Finance had a severe share..

ImmuPharma Q&A: More positive news will continue to strengthen share price (LON:IMM)

ImmuPharma's Tim McCarthy discusses their licencing & development agreement with Avion, the Lanstead deal and the key investment points for investing in IMM in this exclusive interview with DirectorsTalk...

Gresham House Strategic MD Q&A with Graham Bird (LON:GHS)

Gresham House Strategic (LON:GHS) Managing Director Graham Bird caught up with DirectorsTalk for an exclusive interview to discuss financial and investment management highlights, post period performance and the outlook for..

Premier Miton Investors Q&A with Head of Equities Gervais Williams (LON:PMI)

Premier Miton Investors (LON:PMI) Head of Equities Gervais Williams caught up with DirectorsTalk for an exclusive interview to discuss Morgan Stanley’s view on UK equities, how attractive the FTSE Small..

Sativa Group Q&A: New appointments, medicinal cannabis licence & admission to AIM (NEX:SATI)

Sativa Group (NEX:SATI) Chief Executive Officer Henry Lees-Buckley caught up with DirectorsTalk for an exclusive interview to discuss the new appointments in the Group, the progress of the cannabis cultivation..

Cambria Automobiles Q&A “Results are very impressive” (LON:CAMB)

Cambria Automobiles (LON:CAMB) is the topic of conversation when Zeus Capital’s Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview. Q1: Cambria Automobiles has released full..

Search

Funds

Q & A

ImmuPharma Q&A: More positive news will continue to strengthen share price (LON:IMM)

ImmuPharma's Tim McCarthy discusses their licencing & development agreement with Avion, the Lanstead deal and the key investment points for investing in IMM in this exclusive interview with DirectorsTalk...
Search

Funds

Q & A

FTSE 100

Funds